Greatbatch Inc. announced it has filed a Form 10 registration statement with the U.S. Securities and Exchange Commission for its proposed tax-free spin-off of its neuromodulation subsidiary, QiG Group LLC, to be known post-spin as Nuvectra Corporation. Scott Drees has been named as Nuvectra's chief executive officer. In addition, Dr. Joseph A. Miller, Jr. will step down from Greatbatch's board of directors immediately prior to the completion of the spin-off to accept an appointment as a director and chairman of the board of Nuvectra.

Mr. Drees was a founding Board member of the National Pain Foundation, and currently serves on the Board of Directors at Neuros Medical Inc. Prior to ANSI, Mr. Drees held a wide variety of positions at St. Jude Medical, Boston Scientific and Johnson & Johnson's Codman division.